167 related articles for article (PubMed ID: 38526643)
21. Potential Anti-Metastatic Role of the Novel miR-CT3 in Tumor Angiogenesis and Osteosarcoma Invasion.
Raimondi L; Gallo A; Cuscino N; De Luca A; Costa V; Carina V; Bellavia D; Bulati M; Alessandro R; Fini M; Conaldi PG; Giavaresi G
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054891
[TBL] [Abstract][Full Text] [Related]
22. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.
Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC
Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450
[TBL] [Abstract][Full Text] [Related]
23. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
Zucchini C; Manara MC; Cristalli C; Carrabotta M; Greco S; Pinca RS; Ferrari C; Landuzzi L; Pasello M; Lollini PL; Gambarotti M; Donati DM; Scotlandi K
J Exp Clin Cancer Res; 2019 Dec; 38(1):503. PubMed ID: 31878963
[TBL] [Abstract][Full Text] [Related]
24. Exploring the impact of PDGFD in osteosarcoma metastasis through single-cell sequencing analysis.
Huang Y; Cao D; Zhang M; Yang Y; Niu G; Tang L; Shen Z; Zhang Z; Bai Y; Min D; He A
Cell Oncol (Dordr); 2024 Apr; ():. PubMed ID: 38652223
[TBL] [Abstract][Full Text] [Related]
25. Research progress in the mechanism and treatment of osteosarcoma.
Bian J; Liu Y; Zhao X; Meng C; Zhang Y; Duan Y; Wang G
Chin Med J (Engl); 2023 Oct; 136(20):2412-2420. PubMed ID: 37649421
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the Tumor Microenvironment in Osteosarcoma Identifies Prognostic- and Immunotherapy-Relevant Gene Signatures.
Tan J; Feng X; Wu H; Yang B; Shi M; Xie C; Su Z; Li L; Luo M; Zuo Z; Zhu S; Yang J; Lin L
J Immunol Res; 2022; 2022():6568278. PubMed ID: 36065454
[TBL] [Abstract][Full Text] [Related]
27. Analysis of antitumor immunity in mouse glioma microenvironment through intercellular communication.
Zhang Y; Lu F; Cai N; Tang L; Zhou Y; Li Y; Liu K; Song W; Kang L; He H
J Cancer Res Ther; 2022 Sep; 18(5):1397-1408. PubMed ID: 36204889
[TBL] [Abstract][Full Text] [Related]
28. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
29. Single-cell RNA sequencing reveals the cellular and molecular heterogeneity of treatment-naïve primary osteosarcoma in dogs.
Ammons D; Hopkins L; Cronise K; Kurihara J; Regan D; Dow S
Res Sq; 2023 Aug; ():. PubMed ID: 37609233
[TBL] [Abstract][Full Text] [Related]
30. Single-cell transcriptomics reveals the regulative roles of cancer associated fibroblasts in tumor immune microenvironment of recurrent osteosarcoma.
Huang X; Wang L; Guo H; Zhang W; Shao Z
Theranostics; 2022; 12(13):5877-5887. PubMed ID: 35966586
[No Abstract] [Full Text] [Related]
31. TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome.
Ribi S; Baumhoer D; Lee K; Edison ; Teo AS; Madan B; Zhang K; Kohlmann WK; Yao F; Lee WH; Hoi Q; Cai S; Woo XY; Tan P; Jundt G; Smida J; Nathrath M; Sung WK; Schiffman JD; Virshup DM; Hillmer AM
Oncotarget; 2015 Apr; 6(10):7727-40. PubMed ID: 25762628
[TBL] [Abstract][Full Text] [Related]
32. RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation.
Szołtysek K; Janus P; Zając G; Stokowy T; Walaszczyk A; Widłak W; Wojtaś B; Gielniewski B; Cockell S; Perkins ND; Kimmel M; Widlak P
BMC Genomics; 2018 Nov; 19(1):813. PubMed ID: 30419821
[TBL] [Abstract][Full Text] [Related]
33. Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients.
Zhao S; Wang Q; Ni K; Zhang P; Liu Y; Xie J; Ji W; Cheng C; Zhou Q
Front Immunol; 2023; 14():1263329. PubMed ID: 37727789
[TBL] [Abstract][Full Text] [Related]
34. Fluorescent In Situ Hybridization for TP53 in the Diagnosis of Pediatric Osteogenic Sarcoma.
Marrano P; Shago M; Somers GR; Thorner PS
Am J Surg Pathol; 2018 Jun; 42(6):744-749. PubMed ID: 29543677
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
Li KW; Wang SH; Wei X; Hou YZ; Li ZH
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
[TBL] [Abstract][Full Text] [Related]
36. Metabolic Landscape of Osteosarcoma: Reprogramming of Lactic Acid Metabolism and Metabolic Communication.
Wang L; Dou X; Xie L; Zhou X; Liu Y; Liu J; Liu X
Front Biosci (Landmark Ed); 2024 Feb; 29(2):83. PubMed ID: 38420794
[TBL] [Abstract][Full Text] [Related]
37. Targeting mutant TP53 as a potential therapeutic strategy for the treatment of osteosarcoma.
Tang F; Min L; Seebacher NA; Li X; Zhou Y; Hornicek FJ; Wei Y; Tu C; Duan Z
J Orthop Res; 2019 Mar; 37(3):789-798. PubMed ID: 30667081
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
39. Modulation of immunosuppressive cells and noncoding RNAs as immunotherapy in osteosarcoma.
Xia Y; Wang D; Piao Y; Chen M; Wang D; Jiang Z; Liu B
Front Immunol; 2022; 13():1025532. PubMed ID: 36457998
[TBL] [Abstract][Full Text] [Related]
40. TP53 in bone and soft tissue sarcomas.
Thoenen E; Curl A; Iwakuma T
Pharmacol Ther; 2019 Oct; 202():149-164. PubMed ID: 31276706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]